Brief: Poly Medicure Says No Major Adverse Impact Of COVID-19 On Co's Business Ops
22/05/2020 12:41
May 22 (Reuters) - Poly Medicure Ltd PLMD.NS :
* THERE IS NO MAJOR ADVERSE IMPACT OF COVID-19 ON CO'S
BUSINESS
OPERATIONS
Source text: https://bit.ly/2zWGaRY
Further company coverage: PLMD.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Poly Medicure
See all newsBrief: Poly Medicure March-Quarter Consol Net Profit 662.9 Million Rupees
Brief: Poly Medicure Says Unit Buys 100% Equity In Medyneo
Brief: Poly Medicure Ltd Says Polymed Brazil Lida To Buy 100% Equity In Medyneo
Brief: Poly Medicure Dec-Quarter Consol Net Profit 709.3 Million Rupees
Brief: Poly Medicure Signs Share Purchase Agreement With Welling Holdings